| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 05/01/2023 | Viking Therapeutics, Inc. | VKTX | Sale | Common Stock, par value $0.00001 per share | 45k | $22.45 | $1M | | 05/01/2023 |
| 04/03/2023 | Viking Therapeutics, Inc. | VKTX | Sale | Common Stock, par value $0.00001 per share | 22k | $17.85 | $392.7k | | 03/30/2023 |
| 04/03/2023 | Viking Therapeutics, Inc. | VKTX | Grant | Common Stock, par value $0.00001 per share | 300k | $0.00 | $0 | | 03/30/2023 |
| 04/03/2023 | Viking Therapeutics, Inc. | VKTX | Payment of Exercise | Common Stock, par value $0.00001 per share | 200k | $17.57 | $3.5M | | 03/30/2023 |
| 03/31/2023 | Viking Therapeutics, Inc. | VKTX | Sale | Common Stock, par value $0.00001 per share | 68k | $17.45 | $1.2M | | 03/30/2023 |
| 03/31/2023 | Viking Therapeutics, Inc. | VKTX | Exercise | Stock Option (Right to Buy) | 68k | $9.49 | $645k | | 03/30/2023 |
| 03/30/2023 | Viking Therapeutics, Inc. | VKTX | Sale | Common Stock, par value $0.00001 per share | 88k | $16.95 | $1.5M | | 03/30/2023 |
| 03/30/2023 | Viking Therapeutics, Inc. | VKTX | Sale | Common Stock, par value $0.00001 per share | 65.4k | $17.45 | $1.1M | | 03/30/2023 |
| 03/30/2023 | Viking Therapeutics, Inc. | VKTX | Exercise | Stock Option (Right to Buy) | 115.9k | $1.23 | $142.5k | | 03/30/2023 |
| 03/30/2023 | Viking Therapeutics, Inc. | VKTX | Exercise | Stock Option (Right to Buy) | 19.5k | $9.49 | $185.3k | | 03/30/2023 |
| 01/05/2023 | SEELOS THERAPEUTICS, INC. | APRI | Grant | Stock Option (right to buy) | 50k | $0.81 | $40.5k | | 01/05/2023 |
| 01/04/2023 | Viking Therapeutics, Inc. | VKTX | Payment of Exercise | Common Stock, par value $0.00001 per share | 28.6k | $8.42 | $241k | | 12/30/2022 |
| 01/03/2023 | Viking Therapeutics, Inc. | VKTX | Grant | Stock Option (Right to Buy) | 600k | $8.52 | $5.1M | | 12/30/2022 |
| 01/03/2023 | Viking Therapeutics, Inc. | VKTX | Grant | Common Stock, par value $0.00001 per share | 266.7k | $0.00 | $0 | | 12/30/2022 |
| 01/03/2023 | Viking Therapeutics, Inc. | VKTX | Payment of Exercise | Common Stock, par value $0.00001 per share | 68.3k | $8.52 | $581.5k | | 12/30/2022 |
| 12/30/2022 | Viking Therapeutics, Inc. | VKTX | Grant | Common Stock, par value $0.00001 per share | 121.7k | $0.00 | $0 | | 12/30/2022 |
| 12/30/2022 | Viking Therapeutics, Inc. | VKTX | Payment of Exercise | Common Stock, par value $0.00001 per share | 66.1k | $9.40 | $621.6k | | 12/30/2022 |
| 01/05/2022 | SEELOS THERAPEUTICS, INC. | APRI | Grant | Stock Option (right to buy) | 35k | $1.56 | $54.6k | | 01/05/2022 |
| 01/04/2022 | Viking Therapeutics, Inc. | VKTX | Payment of Exercise | Common Stock, par value $0.00001 per share | 26.4k | $4.62 | $122.1k | | 01/03/2022 |
| 01/03/2022 | Viking Therapeutics, Inc. | VKTX | Grant | Common Stock, par value $0.00001 per share | 173.3k | $0.00 | $0 | | 01/03/2022 |
| 01/03/2022 | Viking Therapeutics, Inc. | VKTX | Payment of Exercise | Common Stock, par value $0.00001 per share | 36.3k | $4.88 | $177.2k | | 01/03/2022 |
| 01/03/2022 | Viking Therapeutics, Inc. | VKTX | Grant | Stock Option (Right to Buy) | 390k | $4.88 | $1.9M | | 01/03/2022 |
| 09/28/2021 | Viking Therapeutics, Inc. | VKTX | Grant | Common Stock, par value $0.00001 per share | 55.5k | $0.00 | $0 | | 09/28/2021 |
| 09/28/2021 | Viking Therapeutics, Inc. | VKTX | Payment of Exercise | Common Stock, par value $0.00001 per share | 27.8k | $6.50 | $180.4k | | 09/28/2021 |
| 01/19/2021 | Viking Therapeutics, Inc. | VKTX | Payment of Exercise | Common Stock, par value $0.00001 per share | 5.6k | $6.68 | $37.5k | | 01/19/2021 |
| 01/06/2021 | SEELOS THERAPEUTICS, INC. | APRI | Grant | Stock Option (right to buy) | 16k | $1.35 | $21.6k | | 01/06/2021 |
| 09/15/2020 | Viking Therapeutics, Inc. | VKTX | Payment of Exercise | Common Stock | 19.2k | $6.25 | $120k | | 09/15/2020 |
| 09/15/2020 | Viking Therapeutics, Inc. | VKTX | Grant | Common Stock | 55.5k | $0.00 | $0 | | 09/15/2020 |
| 01/19/2020 | Viking Therapeutics, Inc. | VKTX | Payment of Exercise | Common Stock, par value $0.00001 per share | 3.2k | $7.18 | $22.9k | | 01/19/2020 |
| 01/06/2020 | SEELOS THERAPEUTICS, INC. | APRI | Grant | Stock Option (right to buy) | 16k | $1.42 | $22.7k | | 01/06/2020 |
| 01/03/2020 | Viking Therapeutics, Inc. | VKTX | Grant | Common Stock, par value $0.00001 per share | 153.3k | $0.00 | $0 | | 01/03/2020 |
| 01/03/2020 | Viking Therapeutics, Inc. | VKTX | Payment of Exercise | Common Stock, par value $0.00001 per share | 6.8k | $7.77 | $52.7k | | 01/03/2020 |
| 01/03/2020 | Viking Therapeutics, Inc. | VKTX | Grant | Stock Option (Right to Buy) | 345k | $7.77 | $2.7M | | 01/03/2020 |
| 03/20/2019 | SEELOS THERAPEUTICS, INC. | APRI | Grant | Stock Option (right to buy) | 16k | $2.33 | $37.3k | | 03/20/2019 |
| 03/20/2019 | SEELOS THERAPEUTICS, INC. | APRI | Grant | Stock Option (right to buy) | 24k | $2.33 | $55.9k | | 03/20/2019 |
|